Back

Sex Differences In Pharmacologic Optimal Medical Therapy For Ischemic Heart Disease, 2010-2020: An Observational Study

2025-07-10 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundDespite guideline recommendations for optimal medical therapy (OMT) in the secondary prevention of ischemic heart disease (IHD)--including antiplatelets, statins, renin-angiotensin-aldosterone system inhibitors (RAASi), and {beta}-blockers--substantial sex disparities in OMT utilization persist. The extent to which national efforts have mitigated these disparities in contemporary cohorts remains unclear. MethodsWe analyzed data from the 2011-2020 National Health and Nutrition Examinat...

Predicted journal destinations